GlycoEra AG is advancing glycoengineered therapeutics to address unmet medical needs. Despite significant advancements in understanding the role of glycans in human health and diseases, this knowledge has not translated well into therapeutic drug development, a consequence of the limitations and complexities of controlling glycosylation processes. GlycoEra’s platform has overcome these challenges. The CustomGlycan Platform enables glycan-mediated modes of action through the engineering of highly defined specific glycan structures, accessing a novel combinatorial dimension for the treatment of very challenging diseases.

Biotechnology

GlycoEra

Dominique Sirena

Amir Faridmoayer

Tanmoy Ganguly

Greg Fralish

The Research and Science team at GlycoEra is responsible for advancing the development of glycoengineered therapeutics. They focus on the discovery, design, and optimization of specific glycan structures using the CustomGlycan Platform, aiming to create novel treatments for challenging diseases. The team leverages expertise in molecular biology, fermentation, and translational research to translate glycoscience breakthroughs into viable therapeutic drugs.

Research and Science

About

Team members

Other teams at GlycoEra

Directors Team

Leadership Team